PharmaCyte Biotech, Inc. - stock earnings

PMCB Quarterly earnings

DateEarningsRevenue
2023Q1 -764136 USD ? USD
2022Q4 -1.9 million USD ? USD
2022Q3 -1.5 million USD ? USD
2022Q2 -1.4 million USD ? USD
2022Q1 -811290 USD ? USD
2021Q4 -979746 USD ? USD
2021Q3 -1.0 million USD ? USD
2021Q2 -960004 USD ? USD
2021Q1 -757096 USD ? USD
2020Q4 -950192 USD ? USD

PMCB Yearly earnings

DateEarningsRevenue
2023 -4.3 million USD ? USD
2022 -4.1 million USD ? USD
2021 -3.6 million USD ? USD
2020 -3.8 million USD ? USD
2019 -4.1 million USD ? USD
2018 -6.8 million USD ? USD
2017 -4.4 million USD ? USD
2016 -6.1 million USD ? USD
2015 -10.9 million USD ? USD
2014 -27.3 million USD ? USD
2013 -1.6 million USD 12160 USD
2012 -1.9 million USD 66558 USD
2011 -6.0 million USD 262932 USD
2010 -6.0 million USD 262932 USD
2009 -6.0 million USD 653134 USD
2008 -3.8 million USD 1.2 million USD
2007 -3.6 million USD 1.2 million USD
2006 -9.4 million USD 537038 USD
2005 -4.3 million USD 86374 USD
2004 -1.7 million USD 2383 USD
2003 -32129 USD ? USD
2002 -29847 USD ? USD

PMCB

Price: $2.11

52 week price:
1.92
3.23

Earnings Per Share: -1.48 USD

P/E Ratio: -2.48

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 64200

Market Capitalization: 19.1 million

Links: